A paper in PNAS this week reporting that a signature of microRNA (miRNA) gene expression correlates with diagnosis and prognosis of B-cell chronic lymphocytic leukemias (CLLs) has drawn skepticism ...

The enormous potential of miRNAs is driving new technologies for research, diagnostic, and therapeutic applications. miRNAs, a class of small noncoding RNAs of 19–30 nucleotides in length, regulate ...

MiRNA microarray kits and reagents market is experiencing robust growth driven by rising demand for precision diagnostics, biomarker discovery, and translational research. Expansion of oncology ...

Analyzing gene expression can provide a roadmap for deciphering the role of specific genes or elaborating critical players in functional metabolic pathways. Companies are pursuing solutions to better ...

Prognostic microRNAs in patients operated for pancreatic cancer. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I. This abstract does not include a full text component.

Feb. 1, 2011, 8:45 AM UTC / Source: GlobeNewswire COPENHAGEN, Denmark, Feb. 1, 2011 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ) today announced the launch of its 2011 global research grant program ...

VEDBAEK, Denmark, Jan. 24, 2011 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ), a leading supplier of high-value gene expression analysis products, today announced the launch of the 3rd generation of ...